Avivagen

An Ottawa-based biotech firm that makes a line of natural health products designed to replace antibiotics in livestock feed has announced a multimillion-dollar funding round it says will
Avivagen CEO Cameron Groome was sounding an upbeat tone Friday morning after his company announced it had secured $3.6 million in new funding in a private placement.